Stereotaxis/STXS

$2.96

-2.95%
-
1D1W1MYTD1YMAX

About Stereotaxis

Stereotaxis, Inc. designs, manufactures and markets robotic systems, instruments and information systems for the interventional laboratory. The Company’s robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. The Company also offers its customers the Stereotaxis Imaging Model S X-ray System and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. The Odyssey Solution consolidates lab information onto one large integrated display, enabling physicians to view and control all the key information in the operating room.

Ticker

STXS

Sector

Healthcare

Trading on

AMEX

Industry

Medical Equipment & Supplies

CEO

David Fischel

Employees

130

Headquarters

St. louis, United States

Stereotaxis Metrics

BasicAdvanced
$246.7M
Market cap
-
P/E ratio
-$0.27
EPS
1.34
Beta
-
Dividend rate

What the Analysts think about Stereotaxis

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 5 analysts.
48.65% upside
High $5.00
Low $3.00
$2.96
Current price
$4.40
Average price target

Stereotaxis Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-68.83% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$7.7M
-1.28%
Net income
$-5.3M
8.16%
Profit margin
-68.83%
9.57%

Stereotaxis Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 15.51%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.06
-$0.07
-$0.07
-$0.07
-
Expected
-$0.07
-$0.06
-$0.07
-$0.06
-$0.07
Surprise
-10%
21.21%
-3.05%
15.51%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Stereotaxis stock

Buy or sell Stereotaxis stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing